Medical News

Dimensions of Apathy in Parkinson's Disease
Brain Behav.

This work provides further evidence for a distinct pattern of apathy in people with PD in which deficits manifest...

22 May 2023

Perioperative Acute Ischemic Stroke in Patients with Atrial...
Ann Neurol.

In AF patients, periprocedural AIS risk increases with the CHA2DS2VASc score, active cancer, and cardiovascular or...

18 May 2023

The Association between Age & Inflammatory Disease Activ...
Eur J Neurol.

Higher age is associated with a lower risk of inflammatory MRI activity at baseline and during long-term follow-up...

15 May 2023

A Scoring Tool to Predict Mortality and Dependency after CVT
Eur J Neurol.

The SI2NCAL2C score shows adequate performance for estimating individual risk of mortality and dependency after...

11 May 2023

Our Publications

DSM Dilemma: Issue 5

The current issue of  DSM dilemma attempts to give a comprehensive outlook on one of the important controversial revisions of DSM-5: changes in the...

DSM Dilemma: Issue 4

‘‘DSM Dilemma endeavors to bring to light DSM-5’s biggest changes and the possible impact they may have on mental health care. The fourth issue of...

DSM Dilemma: Issue 3

The current issue of DSM dilemma attempts to give a comprehensive outlook on one of the important criticism faced by DSM-5: over medicalising mental...

DSM Dilemma: Issue 2

The current issue of DSM Dilemma is a comprehensive guide of DSM-5 highlighting the major additions and revisions.

Patient Education

Understanding Parkinson’s Disease

The article consists of basic information on Parkinson’s disease, its common features, management and tips to cope with the disease.  

Mental Health in Old Age

This slide set contains basic understanding of common mental health problems in old age, early warning signs and tips for better mental health care....

Substance Abuse

This slide set discusses the issue of substance abuse in India with the risk factors, common reasons, early signs, and treatment of substance abuse....

Attention Deficit Hyperactivity Disorder (ADHD)

This slide set contains general understanding of principal features, risk factors, and treatment for ADHD in children and adults.  

Key Trials

Impact of IR/ER Amantadine on LID in PD: Analysis of the ALLAY-LID Trials

IR/ER-amantadine significantly reduced the severity of dyskinesia in one of two studies and in the pooled analysis. The safety profile for IR/ER-...

Rizatriptan vs. other Triptans on Stringent Measures of Efficacy in Migraine Patients

The study demonstrated that 10 mg rizatriptan was more effective than oral sumatriptan, naratriptan and zolmitriptan in terms of pain-free response...

Amantadine for Management of Dyskinesias in Parkinson’s Disease

The study demonstrated that amantadine effectively controlled dyskinesias in majority of the study population. Patients’ response to amantadine was...

Early Initiation of Rizatriptan to treat a Migraine Attack, Beneficial

TAME1 and TAME 2 studies demonstrated that early administration of rizatriptan following a migraine attack, while the symptoms were mild was...

Slide Library

Mental Health in Old Age

This slide set contains basic understanding of common mental health problems in old age, early warning signs and tips for better mental health care...

 
Email this page
Substance Abuse

This slide set discusses the issue of substance abuse in India with the risk factors, common reasons, early signs, and treatment of substance abuse...

 
Email this page
Attention Deficit Hyperactivity Disorder (ADHD)

This slide set contains general understanding of principal features, risk factors, and treatment for ADHD in children and adults.  

 
Email this page
Mental health

This slide set discusses the importance of mental health, factors contributing to mental health issues, and ways to maintain positive mental health...

 
Email this page

Poll

Which one of the below drugs is most used by you as addition to existing levodopa regimen, for management of Parkinson’s Disease patients?

Pramipexole immediate release
0% (0 votes)
Pramipexole extended release
50% (1 vote)
Ropinirole
0% (0 votes)
Rasagiline
0% (0 votes)
Selegiline
50% (1 vote)
Total votes: 2